Authors



Jill A. Marsteller, PhD, MPP

Latest:

Impact of the Patient-Centered Medical Home on Consistently High-Cost Patients

Patient-centered medical homes in Maryland’s multipayer demonstration disrupted the pattern of recurrently high expenditure among the costliest patients and improved continuity of care.



Anecita Fadol, PhD, RN, FNP, FAANP

Latest:

Importance of a Heart Failure Disease Management Program for Chemotherapy-Induced Toxicity

To promote collaboration and efficiency, the MD Anderson Cancer Center developed an interdisciplinary team—based Heart Success Program to coordinate the management of concurrent cardiomyopathy and HF while the patient is receiving cancer treatment.



Aaron Winn, MPP

Latest:

Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and Consequences

This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.


Marcia Valenstein, MD

Latest:

Depression Care Following Psychiatric Hospitalization in the Veterans Health Administration

Different patient characteristics predict adequate antidepressant treatment after hospitalization, received by 58.7% of patients, versus adequate psychotherapy, received by 12.9% of patients.


Andrew W. Tang, MS

Latest:

Impact of an Online Prescription Management Account on Medication Adherence

Online prescription management accounts may help promote medication adherence, as utilizing patients had a higher proportion of days covered than nonusers.


Rachel Beckerman, PhD

Latest:

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.



Michael Eber, BSE

Latest:

Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.


Richard A. Brook, MS, MBA

Latest:

Absenteeism and Productivity Among Employees Being Treated for Hepatitis C

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.


Melissa Lingohr-Smith, PhD

Latest:

Improving Quality of Care in Oncology Through Healthcare Payment Reform

Overview of alternative payment models and how leading national organizations are involved with linking quality improvement initiatives and payment reform.



James G. Stevenson, PharmD

Latest:

Moving From A to Z: Successful Implementation of a Statin Switch Program by a Large Physician Group

This report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.


Siran M. Koroukian, PhD

Latest:

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.


Farnoosh Haji-Sheikhi, MS

Latest:

Development of a Tailored Survey to Evaluate a Patient-Centered Initiative

We developed short patient experience surveys that were sensitive to our broad quality initiative, were meaningful and acceptable to patients, and had good response rates.


Clemens S. Hong, MD, MPH

Latest:

Can Primary Care Physicians Accurately Predict the Likelihood of Hospitalization in Their Patients?

This study demonstrates that the predictive accuracy of primary care physicians’ assessment of future hospitalization risk is comparable to commonly used quantitative risk stratification instruments.





Ross Zafonte, DO

Latest:

Functional Status and Readmissions in Unilateral Hip Fractures

Functional status is an important predictor of an acute care readmission in patients who have had a unilateral hip fracture.


Deana Ferreri

Latest:

Secondary Patents Not an Issue for Biosimilars in Europe, Study Notes

In Europe, the authors of this new study suggest, some patent barriers may be more illusory than real.



Amy R. Pettit, PhD

Latest:

Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of "Too Much Too Soon"

Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.





Daniel H. Solomon, MD, MPH

Latest:

Adherence to Osteoporosis Medications After Patient and Physician Brief Education: Post Hoc Analysis of a Randomized Controlled Trial

Post hoc analysis of a randomized controlled trial found that a 1-session educational intervention targeted at patients and primary care physicians did not improve osteoporosis medication adherence.


Joan S. Ash, PhD, MLS, MBA

Latest:

The SAFER Guides: Empowering Organizations to Improve the Safety and Effectiveness of Electronic Health Records

We describe the conceptual underpinnings of an EHR-related selfassessment strategy to provide institutions a foundation upon which they can build their safety efforts.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo